News
Dupixent Gets FDA Approval for Eosinophilic Esophagitis
The approval was based on efficacy and safety data from a phase 3 trial, which included two 24-week treatment periods in patients 12 years of age and older with EoE.
Your search for proton pump inhibitor returned 3 results
Drugs in the Pipeline
Vonoprazan NDA Submitted for Erosive Esophagitis
The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.
DX
Osteoarthritis
Osteoarthritis is the leading form of arthritis and growing. With people living longer, by 2030 osteoarthritis is expected to become the single greatest cause of disability globally.
